within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AE10_SodiumZirconiumCyclosili;

model SodiumZirconiumCyclosili
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 1,
    Cl = 0,
    adminDuration = 600,
    adminMass = 10 / 1000000,
    adminCount = 1,
    Vd = 0.001,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.016666666666666666,
    Tlag = 0);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>SodiumZirconiumCyclosilicate</td></tr><tr><td>ATC code:</td><td>V03AE10</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>10</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Sodium zirconium cyclosilicate (SZC) is a non-absorbed, inorganic cation exchange compound used for the treatment of hyperkalemia (elevated serum potassium) in adults. It selectively captures potassium ions in exchange for sodium and hydrogen ions in the gastrointestinal tract, thereby lowering serum potassium. The drug is currently approved and used clinically for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic profile for adult patients with hyperkalemia; healthy individuals; both sexes; data from clinical trials.</p><h4>References</h4><ol><li><p>Penland, RC, et al., &amp; Någård, M (2024). Population Pharmacodynamic Dose-Response Analysis of Serum Potassium Following Dosing with Sodium Zirconium Cyclosilicate. <i>Clinical pharmacokinetics</i> 63(4) 551–560. DOI:<a href=\"https://doi.org/10.1007/s40262-024-01360-9\">10.1007/s40262-024-01360-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38504082/\">https://pubmed.ncbi.nlm.nih.gov/38504082</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.V.V03AE10 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end SodiumZirconiumCyclosili;
